skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Altered sensitivity to mechanical stimulation during prolonged subcutaneous administration of endothelin-1 in rats

Original Research

(2504) Views  (606) Full article downloads

Authors: Guy Hans, Kristof Deseure, Marcel Vercauteren

Published Date May 2009 Volume 2009:2 Pages 67 - 73
DOI: http://dx.doi.org/10.2147/JPR.S5529

Guy Hans1,2,3, Kristof Deseure2,3, Marcel Vercauteren1,2,3

1Multidisciplinary Pain Center; 2Department of Anesthesiology, Antwerp University Hospital, Edegem, Belgium; 3Laboratory of Anesthesiology and Pain Research, University of Antwerp, Wilrijk, Belgium

Abstract: Cancer pain is often difficult to treat. Growing evidence indicates that chemical mediators secreted by the tumor itself play an important role in the development of cancer pain. One such mediator, endothelin-1 (ET-1) is secreted by different tumor types. Studies have indicated that ET-1 induces spontaneous and evoked nociception in rodents and in humans. The focus of all these studies has always been on a single administration of ET-1. Such an acute exposure to ET-1 however bears little resemblance to the clinical condition in which cancer patients are exposed continuously for many months to increased levels of ET-1. To improve the knowledge of the pathological role of ET-1 in cancer, we developed an animal model of prolonged exposure to ET-1. Rats were exposed to subcutaneous administration of ET-1 for seven consecutive days, with a total amount of 67.4 nmol. On days +2, +3, +5, +7, and +10 sensitivity to von Frey hairs and to pin-prick stimulation were evaluated. Prolonged administration of ET-1 induced signs of mechanical allodynia on several time points. Although the administered doses were very small, prolonged administration of ET-1 seems to lead to a state of mechanical allodynia.

Keywords: endothelin-1, rat, chronic administration, von Frey hair, pin-prick, mechanical allodynia






 

Other articles by Professor Guy Hans

Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma
Transdermal buprenorphine – a critical appraisal of its role in pain management
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University